BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 7889201)

  • 1. Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
    Blood Press Suppl; 1994; 5():54-6. PubMed ID: 7889201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Ishimura Y; Chatani F; Iwao H
    J Pharmacol Exp Ther; 1995 Apr; 273(1):509-15. PubMed ID: 7714806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury.
    Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
    Kidney Int; 1994 Nov; 46(5):1346-58. PubMed ID: 7853793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
    Kim S; Iwao H
    J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candesartan prevents the progression of glomerulosclerosis in genetic hypertensive rats.
    Obata J; Nakamura T; Kuroyanagi R; Yoshida Y; Guo DF; Inagami T
    Kidney Int Suppl; 1997 Dec; 63():S229-31. PubMed ID: 9407467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats.
    Obata J; Nakamura T; Takano H; Naito A; Kimura H; Yoshida Y; Shimizu F; Guo DF; Inagami T
    J Hypertens; 2000 Sep; 18(9):1247-55. PubMed ID: 10994756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal protective effects of angiotensin II receptor I antagonist CV-11974 in spontaneously hypertensive stroke-prone rats (SHR-sp).
    Nakamura T; Honma H; Ikeda Y; Kuroyanagi R; Takano H; Obata J; Sato T; Kimura H; Yoshida Y; Tamura K
    Blood Press Suppl; 1994; 5():61-6. PubMed ID: 7889203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ameliorative effects on retinal disorder in diabetic SHRSP (stroke-prone spontaneously hypertensive rat)].
    Nagisa Y; Shintani A; Nakagawa S
    Nihon Rinsho; 2002 Oct; 60(10):1975-80. PubMed ID: 12397694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of angiotensin II in glomerulosclerosis of stroke-prone spontaneously hypertensive rats.
    Nakamura T; Obata J; Kuroyanagi R; Kimura H; Ikeda Y; Takano H; Naito A; Sato T; Yoshida Y
    Kidney Int Suppl; 1996 Jun; 55():S109-12. PubMed ID: 8743527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta 1 expression and phenotypic modulation in the kidney of hypertensive rats.
    Hamaguchi A; Kim S; Ohta K; Yagi K; Yukimura T; Miura K; Fukuda T; Iwao H
    Hypertension; 1995 Jul; 26(1):199-207. PubMed ID: 7541781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats.
    Bennai F; Morsing P; Paliege A; Ketteler M; Mayer B; Tapp R; Bachmann S
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S104-15. PubMed ID: 9892150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.
    Inada Y; Wada T; Ojima M; Sanada T; Shibouta Y; Kanagawa R; Ishimura Y; Fujisawa Y; Nishikawa K
    Clin Exp Hypertens; 1997 Oct; 19(7):1079-99. PubMed ID: 9310205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular dimensions in spontaneously hypertensive rats: effects of AT1 antagonism.
    Kett MM; Alcorn D; Bertram JF; Anderson WP
    J Hypertens; 1996 Jan; 14(1):107-13. PubMed ID: 12013482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonpeptide angiotensin II type 1 receptor antagonist prevents nephrosclerosis in hypertensive rats.
    Kanno Y; Okada H; Suzuki H; Ikenaga H; Saruta T
    Blood Press Suppl; 1994; 5():67-70. PubMed ID: 7889204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II receptor antagonist, TCV-116, prevents myocardial hypertrophy in spontaneously hypertensive rats.
    Kagoshima T; Masuda J; Sutani T; Sakaguchi Y; Tsuchihashi M; Tsuruta S; Iwano M; Dohi K; Nakamura Y; Konishi N
    Blood Press Suppl; 1994; 5():89-93. PubMed ID: 7889210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin AT1 receptor antagonism and protection against cardiovascular end-organ damage.
    Nishikawa K
    J Hum Hypertens; 1998 May; 12(5):301-9. PubMed ID: 9655651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats.
    Stier CT; Adler LA; Levine S; Chander PN
    J Hypertens Suppl; 1993 Apr; 11(3):S37-42. PubMed ID: 8315518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
    Watanabe D; Tanabe A; Naruse M; Morikawa S; Ezaki T; Takano K
    Hypertens Res; 2009 Sep; 32(9):807-15. PubMed ID: 19662019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats.
    Sasamura H; Shimizu-Hirota R; Nakaya H; Saruta T
    Hypertens Res; 2001 Mar; 24(2):165-72. PubMed ID: 11325076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.